Related Experiment Video
Updated: Jun 3, 2025
11:18
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
16.0K
The St. Jude Global Academy: A Multifaceted Education Program to Expand Pediatric Oncology Workforce Capacity
Daniel C Moreira1, Saman K Hashmi1, Allyson Andujar1
1Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pediatric Blood & Cancer
|January 6, 2025
Summary
The St. Jude Global Academy (SJGA) trains healthcare professionals worldwide to combat childhood cancer. Its programs improve pediatric cancer care and survival rates by expanding the clinical workforce globally.
Area of Science:
- Global Health
- Pediatric Oncology
- Medical Education
Background:
- A significant global shortage exists for healthcare professionals skilled in pediatric oncology.
- Rising childhood cancer rates necessitate improved access to quality care worldwide.
- St. Jude Global aims to enhance pediatric cancer survival and care access.
Purpose of the Study:
- To describe the St. Jude Global Academy (SJGA) and its educational programs.
- To highlight SJGA's role in training a global clinical workforce for pediatric cancer care.
- To detail the impact of SJGA's initiatives on improving outcomes for children with cancer.
Main Methods:
- Clinical training programs in low- and middle-income countries.
- Structured educational courses in pediatric cancer care.
- Distance learning via the Cure4Kids platform.
Main Results:
- 92 pediatric subspecialists trained through clinical programs.
- 1081 participants completed SJGA courses from 84 countries.
- Over 9000 healthcare professionals utilize the Cure4Kids platform globally.
Conclusions:
- SJGA employs a multifaceted approach to build workforce capacity in pediatric oncology.
- Educational initiatives are crucial for expanding quality care for children with cancer.
- SJGA's programs are essential for improving global outcomes in childhood cancer care.
More Related Videos
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
09:55Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
1.6K
Related Concept Videos
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:28International Nursing Organizations II
954
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
954
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:23International Nursing Organizations I
1.6K
International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
1.6K
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472